Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Baishen Changnuo Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of the Jiangxi Baishen Pharmaceutical Group. The company specializes in the development, manufacturing, and commercialization of Traditional Chinese Medicine (TCM) and modern chemical drug formulations. Its product portfolio is particularly strong in respiratory, gastrointestinal, and pediatric health, featuring well-known brands such as Snake Gall and Chuanbei Liquid. Baishen Changnuo operates large-scale manufacturing facilities that adhere to national GMP standards, ensuring high-quality production of capsules, liquids, and granules. The company leverages an extensive distribution network to maintain a significant market presence throughout mainland China. As part of a vertically integrated group, it benefits from internal resources ranging from medicinal herb cultivation to advanced R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 江西百神昌诺.